<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Rare Disease Endpoint Advancement Pilot Meeting Program</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Rare Disease Endpoint Advancement Pilot Meeting Program</h1>
    <p class="timestamp">Published: 2022-10-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The seventh iteration of the Prescription Drug User Fee Amendments (PDUFA VII) included as part of the FDA User Fee Reauthorization Act of 2022 highlights the goal of advancing and facilitating the development and timely approval of drugs and biological products for rare diseases, including rare diseases in children. The Food and Drug Administration (FDA or Agency) is announcing the Rare Disease Endpoint Advancement Pilot Meeting Program (RDEA Pilot Program) established under the seventh iterati...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2022-23383</p>
    <p><strong>Publication Date:</strong> 2022-10-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/27/2022-23383/rare-disease-endpoint-advancement-pilot-meeting-program">https://www.federalregister.gov/documents/2022/10/27/2022-23383/rare-disease-endpoint-advancement-pilot-meeting-program</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-23383</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
